|
End-of-day quote
Korea S.E.
2026-11-04
|
5-day change | 1st Jan Change | ||
| 200,000.00 KRW | +5.32% |
|
+6.04% | +16.02% |
| Nov. 02 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Oct. 30 | South Korea's FTC Fines Celltrion KRW630 Million Over Subcontracting Violations During Covid-19 Pandemic | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.32% | +6.04% | +9.53% | +9.77% | +16.02% | +20.27% | +52.98% | +15.84% | +164.26% | 32.27B | |
| +10.00% | +5.18% | -11.07% | +15.81% | +64.18% | +54.35% | +71.20% | +12.37% | - | 60.57B | |
| +1.44% | +4.06% | +16.97% | +18.10% | +23.02% | +22.70% | +101.03% | -13.81% | +267.56% | 55.51B | |
| +3.32% | +4.11% | -0.05% | +12.85% | +13.70% | +14.82% | +75.04% | +195.40% | +6,046.30% | 55.22B | |
| +0.46% | -2.86% | +2.16% | +13.04% | +17.03% | +23.34% | +33.77% | +3.61% | +265.31% | 43.27B | |
| +6.42% | +3.20% | +5.50% | +20.40% | +24.35% | +21.14% | +105.56% | +1.09% | +1,107.74% | 40.36B | |
| +2.82% | +7.24% | -3.36% | +9.45% | +150.72% | +236.59% | +801.17% | +503.69% | - | 41.63B | |
| -3.79% | +19.39% | +58.53% | +93.82% | +76.52% | +91.90% | +77.13% | +21.08% | +200.93% | 33.29B | |
| +5.32% | +15.84% | -1.01% | +11.73% | -36.80% | -40.93% | +342.66% | +239.30% | +961.78% | 22.91B | |
| +12.22% | +8.20% | -11.42% | +24.54% | +53.69% | +35.65% | +0.77% | -56.15% | - | 22.52B | |
| +4.35% | +4.18% | -6.40% | -1.68% | -4.73% | -12.75% | -5.30% | -69.30% | - | 21.83B | |
| -1.01% | -2.53% | +9.56% | +14.56% | +16.94% | +10.56% | +139.51% | +192.89% | +2,159.27% | 18.56B | |
| +0.89% | +2.97% | +17.58% | +29.94% | +41.06% | +46.26% | +70.91% | -14.76% | +119.06% | 16.95B | |
| +0.61% | +11.32% | +24.59% | +32.13% | +65.98% | +91.15% | +246.43% | +278.12% | +613.24% | 17.64B | |
| +3.10% | +4.91% | +13.19% | +5.95% | - | - | - | - | - | 16.43B | |
| -7.27% | -9.07% | +12.44% | +41.33% | +63.57% | +82.43% | +79.37% | -15.86% | +384.11% | 16.8B | |
| -0.32% | +11.00% | +25.34% | +28.22% | +11.46% | +20.33% | -21.31% | -26.30% | +164.88% | 15.27B | |
| +2.04% | +5.04% | +7.30% | +7.30% | +195.02% | +178.43% | +351.25% | +1,484.71% | +852.79% | 15.47B | |
| -2.81% | +4.80% | -1.33% | +64.19% | +28.04% | -14.77% | - | - | - | 14.16B | |
| +10.16% | -2.38% | -6.31% | -7.21% | +12.80% | -1.95% | +444.16% | - | - | 12.23B | |
| Average | +2.80% | +3.05% | +8.09% | +22.21% | +43.82% | +46.29% | +164.80% | +161.88% | +1,023.63% | 28.65B | |
| Weighted average by Cap. | +3.30% | +3.19% | +7.02% | +21.25% | +43.54% | +48.87% | +157.08% | +125.26% | +1,340.22% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
